Marielys Otero Maldonado, MD
Infectious Disease · Manati, PRNPI 1649420480
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Merck at 41.1% of the total. Reporting peaked in 2022 at $1,218 and has fallen 84.6% since, to $188 in 2025.
Across 16 payments — averaging $182.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- AbbVie$1K
- Shionogi Inc$241
- Valneva USA, Inc.$184
- Paratek Pharmaceuticals, Inc.$139
- Johnson & Johnson$83
- plus $44 from 1 others
Across 6 payments — averaging $10,787 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$62K
- Merck$3K
What the payments were for
- Consulting fees$75026%
- Speaking & faculty fees$1,12539%
- Food & beverage$1,04436%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $1,200 |
| AbbVie(2 entities) | 6 | $1,027 |
| Shionogi Inc | 2 | $241 |
| Valneva USA, Inc. | 1 | $184 |
| Paratek Pharmaceuticals, Inc. | 1 | $139 |
| Johnson & Johnson | 2 | $83 |
| Gilead | 1 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,919 in reported general payments places this provider in the 75th percentile of 127 infectious disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Manati
- Jorge Santana BagurManati$180K
- Lemuel Martinez BonillaManati$6K
- Marisel Bosques RosadoHato Rey$247K
- Francisco AlvaradoCaguas$69K
- Jorge Bertran-PasarellHato Rey$64K
- Joel Munoz CoreanoBayamon$59K
- Vanessa Olivo EchavarrySan Juan$41K
- Carlos Guzman OrtizAibonito$38K
- Angeles Rodriguez RosaSan Juan$27K
- Miguel Colon PerezSan Juan$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.